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The cloning of the gene responsible for obesity in the ob/ob
mouse in 1994 and the resulting discovery of leptin (1) has
spawned a flurry of investigation into the biology of this novel
adipocyte hormone, with > 600 papers currently in the MED-
LINE database. Studies in human subjects have primarily exam-
ined circulating leptin concentrations under a variety of physio-
logic and pathophysiologic conditions. Numerous studies have
reported that circulating leptin concentrations are highly corre-
lated with adiposity (2). In contrast, investigations of the actions
of leptin have been conducted almost exclusively in rodents. In
the ob/ob mouse, a mutation of the leptin gene causes leptin defi-
ciency and results in hyperphagia, decreased energy expenditure,
severe obesity, and insulin-resistant diabetes (1). Central or
peripheral administration of leptin to rodents leads to acute
decreases in food intake; chronic administration of leptin results
in marked reductions in body fat (2). The efficacy of small doses
of centrally administered leptin and the presence of leptin recep-
tors in areas of the central nervous system involved in regulating
energy balance, such as the hypothalamus, suggest that the brain
is an important site of leptin action (2).
The study by Luke et al (3) in this issue examined leptin and adi-
posity in three black populations. These investigators found that
both adiposity and circulating leptin concentrations were increased
in US blacks relative to Nigerians and Jamaicans; however, the
relation between leptin and adiposity was not different among the
three populations. Furthermore, this relation was best fit by an
exponential function. Accordingly, leptin concentrations are higher
per unit adiposity in obese than in normal-weight subjects (4), a
finding that has been interpreted to indicate resistance to leptin
action in obese subjects (2). In addition, these investigators con-
firmed the previously reported sex difference in circulating leptin
concentrations: women have higher concentrations than men, even
after the greater adiposity in women is corrected for. This differ-
ence does not appear to be due to an effect of female reproductive
hormones (5), but may result from an inhibitory effect of andro-
gens, from differences in body fat distribution, or both.
At the time the paper by Luke et al (3) was submitted, the con-
sequences of leptin deficiency in humans were unknown. The
finding that circulating leptin concentrations are elevated in most
obese people implies that obesity is associated with leptin resis-
tance and has led to speculation that leptin is simply a marker of
body fat stores with no important role in energy homeostasis in
humans. However, congenital leptin deficiency was reported
recently in two first cousins from a highly cosanguinous family
exhibiting hyperphagia, marked obesity (> 50% body fat), and
essentially undetectable serum leptin concentrations (6). The two
children, an 8-y-old girl weighing 86 kg and a 2-y-old boy
weighing 29 kg, were found to have a frame shift mutation
resulting from a single nucleotide deletion in the protein-coding
region of the leptin gene. The findings in these patients clearly
illustrate, as documented previously in rodents, that the congen-
ital absence of leptin in humans leads to an obese phenotype and
confirm a pivotal role for leptin in the regulation of energy bal-
ance in humans. Additional evidence that leptin is involved in
energy balance in primates is provided by recent studies showing
that leptin administration reduces food intake and activates the
sympathetic nervous system in rhesus monkeys (M Tang-Chris-
tiansen, PJ Havel, RR Jacobs, PJ Larson, JL Cameron, unpub-
lished observations, 1997).
Although circulating leptin concentrations are highly correlat-
ed with adiposity in humans (3, 7, 8) and animals (9), fasting or
energy restriction decreases leptin concentrations acutely and
disproportionately to the relatively modest changes in adiposity
(7–10). Thus, factors other than adipose tissue mass are likely to
influence leptin secretion. Several studies conducted in vivo and
in vitro suggest that insulin and glucose may regulate leptin
secretion. For example, infusion of small amounts of glucose
sufficient to prevent a decrease in glycemia and insulinemia dur-
ing fasting in humans also prevents a decrease in plasma leptin
(10). In addition, the decrease in circulating leptin concentra-
tions during energy restriction in humans is related closely to the
decrease in plasma glucose (8). Thus, adipocyte glucose metab-
olism may be involved in the regulation of leptin secretion. Con-
sistent with this hypothesis, we reported recently that glucose
uptake and utilization are important determinants of leptin
expression and secretion from isolated adipocytes (11). There-
fore, changes in adipose tissue glucose metabolism may be
involved in the effects of fasting and refeeding on circulating
leptin concentrations in vivo (7–10). A better understanding of
the mechanisms regulating leptin synthesis and secretion may
lead to pharmacologic approaches for treating obesity by aug-
menting endogenous leptin production.
Resistance to the actions of leptin could occur at several points
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in the leptin signaling pathway. For example, leptin is hypothe-
sized to enter the brain via transport across the blood-brain 
barrier. Mice with diet-induced obesity (12, 13) and polygenic
obesity (the New Zealand mouse) (13) are resistant to the effects
of peripheral but not central leptin administration to reduce food
intake, suggesting a potential defect in the transport of leptin into
the central nervous system. Reduced central nervous system trans-
port of leptin may also occur in obese humans because the ratio of
cerebrospinal fluid to plasma leptin is reduced in obese compared
with lean individuals (14). Another potential mechanism for leptin
resistance is the failure of leptin to activate the leptin receptor.
This defect is observed in obese rodent models with mutations of
the leptin receptor gene (db/db mice and fa/fa Zucker rats) and
produces complete leptin resistance (2). However, leptin receptor
mutations have yet to be reported in humans. Alternatively, postre-
ceptor defects in the leptin signal transduction pathway or a fail-
ure of leptin to act on its hypothalamic targets such as neuropep-
tide Y - or melanocortin-containing neurons (15) could result in an
apparent resistance to leptin action. Accordingly, the agouti (Ay)
mouse, which develops obesity as a result of ectopic production of
an antagonist of melanocortin receptors, exhibits resistance to
both peripheral and central leptin administration (13), suggesting
a defect downstream from the leptin receptor.
An additional possibility is that the leptin signal to the hypo-
thalamus can be overcome by the hedonic qualities of highly
palatable foods. This idea is supported by a recent study in rats
with diet-induced obesity in which central leptin administration
reduced the intake of a standard rodent diet but not that of a more
palatable high-energy diet (16). This is an important considera-
tion to the extent that consumption of a highly palatable, high-fat
diet contributes to obesity in humans. Ultimately, clinical trials
with leptin administration in human subjects will be necessary to
determine the usefulness of leptin or leptin secretagogues in the
treatment of obesity, and the extent to which hedonic factors
influence the response to leptin in humans.
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